Issue 17, 2017, Issue in Progress

Correction: Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation

Abstract

Correction for ‘Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation’ by Heying Pei et al., RSC Adv., 2016, 6, 52518–52527.

Associated articles

Article information

Article type
Correction
Submitted
10 Jan 2017
Accepted
10 Jan 2017
First published
07 Feb 2017
This article is Open Access
Creative Commons BY license

RSC Adv., 2017,7, 10432-10432

Correction: Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation

H. Pei, C. Xie, Y. Liu, M. Shao, J. Chen, D. Li, L. Ma and L. Chen, RSC Adv., 2017, 7, 10432 DOI: 10.1039/C7RA90003A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements